Propranolol: useful therapeutic agent for the treatment of ulcerated infantile hemangiomas

被引:30
|
作者
Kim, Lawrence H. C. [1 ]
Hogeling, Marcia [2 ]
Wargon, Orli [2 ]
Jiwane, Ashish [1 ]
Adams, Susan [1 ]
机构
[1] Sydney Childrens Hosp, Dept Pediat Surg, Randwick, NSW, Australia
[2] Sydney Childrens Hosp, Dept Pediat Dermatol, Randwick, NSW, Australia
关键词
Ulceration; Infantile hemangioma; Propranolol; PULSED-DYE-LASER; CAPILLARY ENDOTHELIAL-CELLS; GROWTH-FACTOR; CLINICAL CHARACTERISTICS; CUTANEOUS HEMANGIOMAS; INFANCY; MANAGEMENT; COMPLICATIONS; INVOLUTION; APOPTOSIS;
D O I
10.1016/j.jpedsurg.2011.01.012
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Infantile hemangioma (IH) is the most common vascular tumor in early childhood. Ulceration is the most frequent complication, and its management can be challenging. We present 6 cases of ulcerated IH at a single pediatric center, which responded to oral propranolol within 2 to 6 weeks. We recommend that oral propranolol therapy be considered for the management of ulcerated IH as first-line treatment. Crown Copyright (C) 2011 Published by Elsevier Inc. All rights reserved.
引用
收藏
页码:759 / 763
页数:5
相关论文
共 50 条
  • [1] Propranolol for treatment of ulcerated infantile hemangiomas
    Saint-Jean, Melanie
    Leaute-Labreze, Christine
    Mazereeuw-Hautier, Juliette
    Bodak, Nathalie
    Hamel-Teillac, Dominique
    Kupfer-Bessaguet, Ingrid
    Lacour, Jean-Philippe
    Naouri, Michael
    Vabres, Pierre
    Hadj-Rabia, Smail
    Nguyen, Jean-Michel
    Stalder, Jean-Francois
    Barbarot, Sebastien
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2011, 64 (05) : 827 - 832
  • [2] Propranolol versus steroids for the treatment of ulcerated infantile hemangiomas
    Polites, Stephanie F.
    Rodrigue, Bentley B.
    Chute, Carol
    Hammill, Adrienne
    Dasgupta, Roshni
    PEDIATRIC BLOOD & CANCER, 2018, 65 (10)
  • [3] Topical propranolol for treatment of superficial infantile hemangiomas
    Xu, Guangqi
    Lv, Renrong
    Zhao, Zhongfang
    Huo, Ran
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2012, 67 (06) : 1210 - 1213
  • [4] Propranolol treatment for infantile hemangiomas
    Buckmiller, Lisa M.
    CURRENT OPINION IN OTOLARYNGOLOGY & HEAD AND NECK SURGERY, 2009, 17 (06) : 458 - 459
  • [5] Propranolol in the Treatment of Infantile Hemangiomas
    Tan, Xin
    Guo, Shu
    Wang, Chenchao
    CLINICAL COSMETIC AND INVESTIGATIONAL DERMATOLOGY, 2021, 14 : 1155 - 1163
  • [6] Oral propranolol: an effective, safe treatment for infantile hemangiomas
    Zaher, Hesham
    Rasheed, Hoda
    Hegazy, Rehab A.
    Hegazy, Ranya A.
    Abdelhalim, Dalia M.
    Gawdat, Heba I.
    EUROPEAN JOURNAL OF DERMATOLOGY, 2011, 21 (04) : 558 - 563
  • [7] Propranolol for treatment of infantile hemangiomas
    de Melo, Juliana Nakano
    Rotter, Anita
    Rivitti-Machado, Maria Cecilia
    Prado de Oliveira, Zilda Najjar
    ANAIS BRASILEIROS DE DERMATOLOGIA, 2013, 88 (06) : 220 - 223
  • [8] A novel topical nano-propranolol for treatment of infantile hemangiomas
    Chen, Zheng Gang
    Zheng, Jia Wei
    Yuan, Ming Lu
    Zhang, Ling
    Yuan, Wei En
    NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE, 2015, 11 (05) : 1109 - 1115
  • [9] Propranolol for Surgeons in the Treatment of Infantile Hemangiomas
    Sinha, Shiba
    Lloyd, Mark Sheldon
    JOURNAL OF CRANIOFACIAL SURGERY, 2020, 31 (01) : 134 - 137
  • [10] Propranolol for the Treatment of Orbital Infantile Hemangiomas
    Fridman, Gretta
    Grieser, Eric
    Hill, Robert
    Khuddus, Nausheen
    Bersani, Tom
    Slonim, Charles
    OPHTHALMIC PLASTIC AND RECONSTRUCTIVE SURGERY, 2011, 27 (03) : 190 - 194